Tian Zhang
University of Texas Southwestern Medical Center · Duke University · Alliance for Clinical Trials in Oncology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tian Zhang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:49 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05931393 · Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)University of Texas Southwestern Medical Center · recruiting · RCC, Renal Cell Carcinoma · principal investigator
- Ph1NCT04073160 · TRIO Bladder: A Study of Durvalumab Plus Tremelimumab Followed by Concurrent Durvalumab Plus Bladder Radiation in Muscle-Invasive Bladder CancerDaniel George, MD · withdrawn · Bladder Cancer · principal investigator
- Ph3NCT03793166 · Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE StudyNational Cancer Institute (NCI) · active not recruiting · Clear Cell Renal Cell Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes · principal investigator
- Ph2NCT03311555 · A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)Andrew J. Armstrong, MD · completed · Prostate Cancer · principal investigator
- Early Ph1NCT02325999 · Endoscopic Submucosal Dissection Combine With Laparoscopic Regional Lymph Node Dissection for Early Gastric CancerBeijing Friendship Hospital · unknown · Early Gastric Cancer · study chair
- Ph3NCT01496521 · Chemoprevention of Esophageal Squamous Cell Carcinoma (ESCC) With Aspirin and Tea PolyphenolsBeijing Friendship Hospital · unknown · Carcinoma, Squamous Cell · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Research specialist award to support PDIGREE (A031704) and implementation of NCI supported clinical trials at Simmons Comprehensive Cancer CenterR50CA305190 · NCI · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2026 · $164,513 awarded in 2026Same name and institution; not confirmed by an ID
- The dissection of non-canonical cis-regulatory elements downstream of beta-globin locus in the fetal hemoglobin gene regulationR01HL170115 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2023 to 2026 · $446,729 awarded in 2026Same name and institution; not confirmed by an ID
- The impact of genetic diversity among Akkermansia strains on the effectivenes of immune checkpoint inhibitors in cancer immunotherapiesR21CA249243 · NCI · DUKE UNIVERSITY · fiscal years 2020 · $188,169 awarded in 2020Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026Named on NCT03793166
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in atypical teratoid rhabdoid tumour (at/rt).